Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Journal Article
Overview
publication date
has subject area
-
Animals
-
Animals, Inbred Strains - Mice, Inbred Strains
-
Biological Factors - Vascular Endothelial Growth Factor A
-
Biological Therapy - Genetic Therapy
-
Cells, Cultured
-
Choroid Diseases - Choroidal Neovascularization
-
Endothelial Cells
-
Genetic Engineering - Genetic Therapy
-
Injections
-
Mice
-
Mice - Mice, Inbred Strains
-
Models, Animal
-
Neovascularization, Pathologic - Choroidal Neovascularization
-
Neovascularization, Pathologic - Retinal Neovascularization
-
Nucleic Acids, Nucleotides, and Nucleosides - RNA, Small Interfering
-
Peptides - Vascular Endothelial Growth Factor A
-
Protein-Tyrosine Kinases - Vascular Endothelial Growth Factor Receptor-1
-
Proteins - Vascular Endothelial Growth Factor A
-
RNA - RNA, Small Interfering
-
RNA, Messenger
-
RNA, Small Untranslated - RNA, Small Interfering
-
Receptors, Cell Surface - Vascular Endothelial Growth Factor Receptor-1
-
Receptors, Growth Factor - Vascular Endothelial Growth Factor Receptor-1
-
Retinal Diseases - Retinal Neovascularization
-
Reverse Transcriptase Polymerase Chain Reaction
has restriction
Date in CU Experts
-
September 9, 2013 10:34 AM
Full Author List
-
Shen J; Samul R; Silva RL; Akiyama H; Liu H; Saishin Y; Hackett SF; Zinnen S; Kossen K; Fosnaugh K
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue